The FINANCIAL - Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
Share This The FINANCIAL -- In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the...
Source: finchannel.com